Title:
Combination of sPLA2 activity for diagnosis/prognosis of a cardiovascular system disease / phenomenon, and OxPL / appointment B cardiovascular system dangerous factor
Document Type and Number:
Japanese Patent JP6012964
Kind Code:
B2
Abstract:
The use of a combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event or for the monitoring of a cardiovascular disease.
More Like This:
| JP2000354492 | NOVEL PROTEIN AND ITS DNA |
| JP2001340084 | NEW PHOSPHODIESTERASE AND GENE ENCODING THE SAME |
| JP4176467 | Methods for comparative analysis of carbohydrate polymers |
Inventors:
Mara, The Ad
Ted Guy, Align
Chimicus, Sochilios
Wittum, Joseph
Ted Guy, Align
Chimicus, Sochilios
Wittum, Joseph
Application Number:
JP2011529572A
Publication Date:
October 25, 2016
Filing Date:
October 02, 2009
Export Citation:
Assignee:
Inselm (Institut National de la Sante de la Richeche Medical)
The Regents of The University of California
University Paris Diderot-Paris 7
The Regents of The University of California
University Paris Diderot-Paris 7
International Classes:
C12Q1/34; C12N9/16; G01N33/53
Foreign References:
| WO2008015546A1 |
Other References:
Arterioscler.Thromb.Vasc.Biol.,2007,Vol.27,p.1788-1795
Attorney, Agent or Firm:
Ryoichi Takaoka